指南与共识流行病学与生物统计

儿童和青少年脂质紊乱筛查:美国预防服务工作组推荐声明

Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
指南 / 共识 · JAMA · 2023-01-01

美国预防服务工作组(USPSTF)委托系统综述评估对无症状儿童和青少年进行脂质紊乱筛查的利弊。该工作组结论认为当前证据不足以评估20岁及以下无症状儿童和青少年筛查的利弊平衡,给出I级声明。

要点

  • 家族性高胆固醇血症和多因素性血脂异常可导致儿童血脂异常升高,增加成年后早发心血管事件风险。
  • USPSTF结论:当前证据不足以评估对20岁及以下无症状儿童和青少年进行脂质紊乱筛查的利弊平衡。
  • 推荐等级为I声明(证据不足)。

核心结论

  • USPSTF结论认为当前证据不足以评估对20岁及以下无症状儿童和青少年进行脂质紊乱筛查的利弊平衡(I声明)。

研究设计与样本

  • USPSTF委托系统综述评估对无症状儿童和青少年进行脂质紊乱筛查的益处与危害。
  • 目标人群为20岁及以下、无已知脂质紊乱诊断的无症状儿童和青少年。

主要发现

  • USPSTF认定当前证据不足,无法确定对20岁及以下无症状儿童和青少年筛查脂质紊乱的利弊平衡。

关键数值与推荐

  • 推荐等级:I声明(证据不足)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Familial hypercholesterolemia and multifactorial dyslipidemia are 2 conditions that cause abnormally high lipid levels in children, which can lead to premature cardiovascular events (eg, myocardial infarction and stroke) and death in adulthood. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for lipid disorders in asymptomatic children and adolescents. POPULATION: Asymptomatic children and adolescents 20 years or younger without a known diagnosis of a lipid disorder. EVIDENCE ASSESSMENT: The USPSTF concludes that the current evidence is insufficient and the balance of benefits and harms for screening for lipid disorders in asymptomatic children and adolescents 20 years or younger cannot be determined. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Barry MJ, Nicholson WK, Silverstein M, et al. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2023. PMID: 37462699. doi:10.1001/jama.2023.11330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。